We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,031

PhRMA pushes for permissive off-label promotion regime
  • McGuireWoods LLP
  • USA
  • May 15 2013

In light of the decision of 2nd U.S. Circuit Court of Appeals in U.S. v. Caronia, the Pharmaceutical Research and Manufacturers of America (PhRMA) is


Standing and certification: Kennedy v. United Am. Ins. Co
  • McGuireWoods LLP
  • USA
  • May 14 2013

Brenda Kennedy was hospitalized in 2009 for four days. She had an insurance policy from United American that paid benefits for each day that she


New FDA guidance on appeals processes for medical device denials
  • McGuireWoods LLP
  • USA
  • May 21 2013

On May 17, 2013, FDA's Center for Devices and Radiological Health (CDRH) published new guidance on maneuvering through the medical device appeals


Weekly Washington healthcare update
  • McGuireWoods LLP
  • USA
  • January 28 2013

Last week, a bipartisan group of House lawmakers led by Reps. Phil Roe (R-TN) and Allyson Schwartz (D-PA) reintroduced legislation on Jan. 23 calling


Weekly Washington healthcare update - March 9, 2015
  • McGuireWoods LLP
  • USA
  • March 9 2015

House Republican Working Group Outlines King v. Burwell “Off-Ramp” Plan... FDA Approves First Biosimilar Product... CMS Approves NH Medicaid Expansion


8 things healthcare providers should know about e-signatures
  • McGuireWoods LLP
  • USA
  • February 2 2015

Electronic signatures can be legally valid to execute documents that require written signatures, and electronic documents can be legally valid when


U.S. Supreme Court to hear North Carolina dental board state-action antitrust case
  • McGuireWoods LLP
  • USA
  • April 9 2014

Last month, the U.S. Supreme Court agreed to review a lower court's decision on the scope of the state-action doctrine, which exempts state actors


CMS finalizes rules for ESRD dialysis payment system and incentive program
  • McGuireWoods LLP
  • USA
  • November 14 2014

Private equity investors continue to be active investors in the dialysis industry, as we've frequently discussed in the past, including in the Law360


7 key lessons for dental practice management companies from corporate integrity agreements
  • McGuireWoods LLP
  • USA
  • October 28 2014

Over the past few years, dental practice management (DPM) companies have come under increasing governmental scrutiny. This is


Weekly Washington healthcare update - August 25, 2014
  • McGuireWoods LLP
  • USA
  • August 25 2014

CMS continues work on Open Payment system... CMS releases guidance on training and certification for ACA Navigators... Treasury Inspector General